The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
MTD · Healthcare · Wide moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | REGN | MTD | CPRX | A |
|---|---|---|---|---|
| Moat Score (0–100) | 81 | 82 (highest) | 82 (highest) | 81 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 29 | 72 | 95 (highest) | 72 |
| Pricing power | 100 (highest) | 97 | 100 (highest) | 90 |
| Returns on capital | 97 (highest) | — | 88 | 84 |
| Balance-sheet safety | 100 (highest) | 67 | 100 (highest) | 71 |
| Capital allocation | 80 | 91 (highest) | 24 | 88 |
| No price data | 248% above value if growth stopped today | 234% above value if growth stopped today (largest discount to value if growth stopped today) | 247% above value if growth stopped today | |
| Market cap | Not reported | $33.4B | $3.9B | $49.7B |
| Moat tier | Wide moat | Wide moat | Wide moat | Wide moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |